Canada markets close in 1 hour 1 minute

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0946-0.0023 (-2.37%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.47M
Enterprise Value 8.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.78
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.84

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-74.71%
S&P500 52-Week Change 3-9.13%
52 Week High 30.6100
52 Week Low 30.0373
50-Day Moving Average 30.0645
200-Day Moving Average 30.1606

Share Statistics

Avg Vol (3 month) 340.5k
Avg Vol (10 day) 38.94k
Shares Outstanding 563.2M
Implied Shares Outstanding 6N/A
Float 8105.49M
% Held by Insiders 11.09%
% Held by Institutions 113.56%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 17, 2016
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.29%
Return on Equity (ttm)-186.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-1.56M
Net Income Avi to Common (ttm)-10.03M
Diluted EPS (ttm)-0.0890
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.4M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)242.51k
Total Debt/Equity (mrq)17.30
Current Ratio (mrq)2.31
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.51M
Levered Free Cash Flow (ttm)-3.74M